CAS: 1712-64-7; Isopropyl Nitrate

上下游产品

CAS号65424-60-4 nitro 2-methylp... | CAS号67-63-0 异丙醇 | CAS号75-26-3 2-溴丙烷 | CAS号108-20-3 异丙醚 | CAS号4399-86-4 isopropyl perox... | CAS号565-75-3 2,3,4-三甲基戊烷 | CAS号74-98-6 丙烷 | CAS号78448-33-6 2-methyl-1-prop... | CAS号107-92-6 正丁酸 | CAS号98-82-8 异丙基苯 | CAS号67-63-0 异丙醇 | CAS号187737-37-7 propene | CAS号10102-44-0 二氧化氮 | CAS号10102-43-9 一氧化氮 | CAS号766-79-0 1-propan-2-ylpi...

2-溴丙烷置于silver Nitrate,苯甲腈体系中,化学反应生成硝酸异丙酯
参考文献:Solvolysis In Hydrogen And Deuterium Oxide: Ii. Strongly Solvated Substrates
标题:Solvolysis In Hydrogen And Deuterium Oxide: Ii. Strongly Solvated Substrates
摘要:在轻水和重水中,给出了一系列极性底物的溶解速率,从中可以获得速率比[公式:见文本].研究的化合物包括甲基,O-甲基,P-甲基,P-甲氧基和p-氟基苯磺酸酯,烷基甲磺酸酯的α-和β-甲基化系列,甲基和异丙基硝酸酯,甲基磷酸酯和硫酸酯,甲烷和苯磺酰氯,以及叔丁基二甲基磺酸盐.尽管氧阴离子酯的反应性存在很大变化,但速率比几乎保持在0.9附近.氯化物的值为0.63,磺酸盐的值为0.95.速率比未能反映由于烷基基团和氧阴离子变化所需的机械变化,这归因于初始状态溶剂化的结构和过渡态中小电荷发展易于饱和影响比率的结构变化.
Doi:10.1139/v57-175

专利信息

专利号:WO-0200681-A1
优先权日:2000-06-27
标题 :20-fluoro-17(20)-vinyl steroids as inhibitors of c17-20-lyase and 5-alpha reductase
发明人：PEET NORTON P; WEINTRAUB PHILIP M; BURKHART JOSEPH P; GATES CYNTHIA A
权利人:AVENTIS PHARMA INC; PEET NORTON P; WEINTRAUB PHILIP M; BURKHART JOSEPH P; GATES CYNTHIA A
摘要:The invention related to 20κ-fluoropregna-4,17(20)-dien-3-on-21-oic acid ethyl ester, 20κ-fluoro-3β-hydroxypregna-4,17(20)-dien-21-oic acid ethyl ester, 20κ-fluoro-21-hydroxypregna-4,17(20)-dien-3-one, 20κ-fluoropregna-4,17(20)-dien-3β,21-diol and related compounds and to compositions incorporating these compounds, as well as the inhibition of C17,20 lyase, 5α-reductase and C17-hydroxylase, and to the use of these compounds in the treatment of androgen and estrogen mediated or dependent disorders, including benign prostatic hyperplasia, prostate cancer, breast cancer and DHT-mediated disorders such as acne and hirsutism. Treatment of disorders related to the over synthesis of cortisol, for example, Cushing's Syndrome are also included. The treatment of androgen-dependent disorders also includes a combination therapy with known androgen-receptor antagonists, such as flutamide. The compounds of the invention have general formulae (I).

专利号:US-4774366-A
优先权日:1985-01-31
标题 :Synthesis of geminal dinitro compounds
发明人：GRAKAUSKAS VYTAUTAS; GARVER LEE C; BAUM KURT
权利人:US AIR FORCE
摘要:Geminal dinitro compounds are prepared by reacting an organic nitro compound having a replaceable hydrogen on the carbon to which the nitro group is attached with a source of nitrite ions in the presence of an oxidizing agent and a catalytic amount of an alkali metal ferricyanide.

专利号:US-8030440-B1
优先权日:2010-05-21
标 题 :Synthesis of poly-(3-nitratooxetane)
发明人：WILLER RODNEY L; BAUM KURT; LIN WEN-HUEY
权利人:FLUOROCHEM INC
摘要:3-nitratooxetane. n Poly-(3-nitratooxetane). n The method of synthesizing 3-nitratooxetane comprising reacting 3-hydroxyoxetane with a nitration agent. n The method of synthesizing poly-(3-nitratooxetane) by polymerizing 3-nitratooxetane using a polyol initiator.

专利号:US-4910322-A
优先权日:1985-01-31
标题 :Synthesis of geminal dinitro compounds
发明人：GRAKAUSKAS VYTAUTAS; GARVER LEE C; BAUM KURT
权利人:US AIR FORCE
摘要:Geminal dinitro compounds are prepared by reacting an organic nitro compound having a replaceable hydrogen on the carbon to which the nitro group is attached with a source of nitrite ions in the presence of an oxidizing agent and a catalytic amount of an alkali metal ferricyanide.

专利号:US-4594430-A
优先权日:1985-01-31
标 题:Synthesis of geminal dinitro compounds
发明人：GRAKAUSKAS VYTAUTAS; GARVER LEE C; BAUM KURT
权利人:US AIR FORCE
摘要:Geminal dinitro compounds are prepared by reacting an organic nitro compound having a replaceable hydrogen on the carbon to which the nitro group is attached with a source of nitrite ions in the presence of an oxidizing agent and a catalytic amount of an alkali metal ferricyanide.

专利号:WO-2006097348-A1
优先权日:2005-03-15
标 题:Use of agents such as nonpolymeric nitric oxide donors for making the lips full again and/or colouring the lips
发明人：CALS-GRIERSON MARIE-MADELEINE
权利人:OREAL; CALS-GRIERSON MARIE-MADELEINE
摘要:The invention relates in particular to the cosmetic use (i) of at least one agent for promoting the production of NO in and/or on the lips, chosen from nitric oxide NO donors or precursors; nonpolymeric NO releasers; and NO synthase synthesis and/or activity stimulators; or (ii) of other agents for promoting microcirculation in the skin, chosen from potassium channel openers; calcium channel blockers; phosphodiesterase inhibitors; flavonoids; vasodilator peptides that are not NO donors; temperature modulators; agents for promoting the stimulation and/or maintenance of angiogenesis; agents for promoting the stimulation of endothelial cell proliferation; agents for promoting endothelial cell migration; and mixtures thereof, in a makeup and/or care composition for the lips, as an agent for naturally making the lips full again and/or naturally coloring the lips. It also relates to specific care and/or makeup compositions for the lips containing said agent, and also to a cosmetic process aimed at making the lips naturally full and/or colored, using said compositions .